I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
A product for proteomics research. Also used as a reagent in the preparation of nitric oxide-donating analogues of Sulindac (S699215), a non-steroidal anti-inflammatory drug that has the ability to prevent colon cancer.
Andrew Nortcliffe; Alexander G. Ekstrom; James R. Black; James A. Ross; Fouad K. Habib; Nigel P. Botting; David OHagan. Synthesis and biological evaluation of nitric oxide-donating analogues of sulindac for prostate cancer treatment.Bioorganic & Medicinal Chemistry.201422(2), 756-761.
Pasricha, P., et al. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.Gastroenterology.1995109(3), 994-998.
Gefahrenhinweise (EU): H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective gloves. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.